期刊文献+

己糖激酶-Ⅱ在直肠癌组织中表达临床意义 被引量:1

The clinical value of Hexokinase-Ⅱ expression in carcinoma of the rectum
下载PDF
导出
摘要 目的:检测己糖激酶-Ⅱ基因在直肠癌组织中表达,探讨其与患者预后的关系。方法:通过逆转录聚合酶链反应(RT-PCR)、蛋白质印迹方法、免疫组织化学方法了解己糖激酶-Ⅱ在直肠癌100例组织中表达,探讨与肿瘤病理因素关系。结果:RT-PCR和蛋白质印迹法结果显示直肠癌组织阳性表达己糖激酶-Ⅱ在RNA水平显著高于正常组织阳性表达。直肠癌组织中己糖激酶-Ⅱ表达阳性率显著高于对照组(P<0.01)。肿瘤大小、分化程度、合并肿瘤分期与己糖激酶-Ⅱ的表达呈正相关(P值分别为P=0.001,P=0.000,P=0.019),而淋巴转移与否与己糖激酶-Ⅱ的表达无相关性(P=0.815)。结论:直肠癌组织中HK-Ⅱ呈高表达,HK-Ⅱ抑制剂能抑制肿瘤糖酵解从而抑制肿瘤生长、增殖,促进肿瘤凋亡,为肿瘤治疗提供契机。 Objective:To study the expression of Hexokinase-II in carcinoma of the rectum,and analyze the relation-ships between HK-II expression and the clinical features. Methods: The expression of HK-II in 100 carcinoma of the rec-tum tissue was checked by using reverse transcriptase polymerase chain reaction,Western blot and inununohistochemistry technique.Then the relationships between HK-II expression and the clinical features of carcinoma of the rectum patients were further investigated,such as tumor sizes,clinical stages,differentiation levels,lymphatic metastasis. Results:RT-PCR re-sult showed that positive expression HK-II in carcinoma of the rectum tissue were higher than that in normal tissue on RNA level.Western blot result showed that positive expression HK-II in carcinoma of the rectum tissue were higher than that in normal tissue on protein level.Inununohistochemistry results showed that the cancer tissue had more positive expres-sion than normal rectal mucosa tissue(P=0.000).Inununohistochemistry results showed that tumor sizes, differentiation lev-els and merger of tumor stages was related with positive expression HK-II (prespectively 0.001,0.000,0.019), lymphatic metastasis was not related with positive expression HK-II (P=0.815). Conclusions:The cancer tissue had more positive HK-II expression than normal rectal mucosa tissue. Tumor sizes,clinical stages and differentiation levels were related with positive expression of HK-II, lymphatic metastasis was not related with positive expression of HK-II.
出处 《交通医学》 2015年第1期20-23,共4页 Medical Journal of Communications
关键词 直肠癌 己糖激酶-Ⅱ 逆转录-聚合酶链反应 蛋白质印迹法 免疫组织化学法 carcinoma of the rectum Hexokinase-II reverse transcriptase polymerase chain reaction Western-blot Inununohistochemistry
  • 相关文献

参考文献8

  • 1Hanahan D,Weinberg RA.Hall marks of cancer:the next Generation[J].Cell,2011,144(5):646-674.
  • 2任东林,郭学峰.新辅助治疗在直肠癌治疗中的应用和评价[J].医学新知,2008,18(2):68-70. 被引量:6
  • 3Warburg O.On the origin of cancer cells[J].Sci ence,1956,123(3191):309-314.
  • 4Pedersen PL,Mathupala S,Rempel A,et al.Mitochondrial bound type II hexokinase:a key player in the growth and survival of many cancers and an ideal prospect for therapeutic intervention[J].Biochim Biophys Acta,2002,1555(1/3):14-20.
  • 5Mathupala SP,Ko YH,Pedersen PL.Hexokinase II:cancer’s double-edged sword acting as both facilitator and gatekeeper of malignancy when bound to mitochondria[J].Oncogene,2006,25(34):4777-4786.
  • 6Burt BM,Humm JL,Kooby DA,et al.Using positron emission tomography with(18)F FDG to predict tumor behavior in experimental colorectal cancer[J].Neoplasia,2001,3(3):189-195.
  • 7Ko YH,Pedersen PL,Geschwind JF.Glucose catabolism in the rabbit VX2 tumor model for liver cancer:characterization and targeting hexokinase[J].Cancer Lett,2001,173(1):83-91.
  • 8Geschwind JF,Georgiades CS,Ko YH,et al.Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma[J].Expert Rev Anticancer Ther,2004,4(3):449-457.

二级参考文献7

  • 1顾晋,詹天成,姚云峰.结直肠癌新辅助化疗[J].中国实用外科杂志,2005,25(5):264-265. 被引量:23
  • 2颜松龄.进展期结直肠癌新辅助治疗现状[J].中国医师进修杂志(外科版),2006,29(9):73-75. 被引量:6
  • 3Zheng S. Rectal study on colorectal cancer in China: early detection and novel related gene [J]. Chinese Med J, 1997, 110(4):309-310.
  • 4Kapiteijin E, Marijnen C A, Nagtegaal I D, et al. Preoperative radiaotherapy combined with total mesorrectal excision for respectable rectal cancer [J]. N Engl J Med, 2001, 345(9): 638-646.
  • 5SRCT. Swedish rectal cancer trail improved survival with reoperative radiotherapy in respectable rectal cancer [J]. N Engl J Med, 2002, 336 (14):980-987.
  • 6Quintela-Fandino M, Gravalos C, Gonzalez E, et al. Irinotecan (CPT- 11)-based chemotherapy as induction treatment for advanced colorectal cancer [J]. Anticancer Drugs, 2005, 16:31-38.
  • 7Bosset J F, Calais G, Daban A, et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance[J]//Report of the 22921 ran- domised trail conducted by the EORTC Radiotherapy Group. Eur J Cancer, 2004, 40:219-224.

共引文献5

同被引文献17

引证文献1

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部